132 results on '"Dell'Agnello, G."'
Search Results
2. PCR70 Factors Associated with Taking Preventive Migraine Medicines: Results from Overcome (EU) Study
3. PCR176 Establishing the Interchangeability Between CSF and PET to Identify Patients With Alzheimer's Disease Pathology
4. Costs and Resource Use Associated with Alzheimer’s Disease in Italy: Results from an Observational Study
5. PCR5 Healthcare Resource Use, Productivity and Quality of Life in Patients With Migraine: Results from Overcome (EU) Study
6. PCR24 The Impact of Informal Caregiving in Alzheimer’s Disease Dementia: A Health Utility Study in the UK
7. PCR59 Assessing the Utility Associated with Caregiving in Alzheimer's Disease (AD) with Mild Cognitive Impairment (MCI) and AD Dementia in Japan
8. Analysis of burden in caregivers of people with Alzheimer’s disease using self-report and supervision hours
9. Childhood neglect and parental care perception in cocaine addicts: Relation with psychiatric symptoms and biological correlates
10. Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients
11. Abstracts Second Congress of the European Society for Clinical Neuropharmacology: Würzburg, November 9–11, 1995
12. Environmental factors and Parkinson's disease: a case–control study in the Tuscany region of Italy
13. Real-world Alzheimer’s disease drug treatment – 18-month results from an observational study in three European countries (GERAS; encore from 2016 EAN)
14. Amantadine in Huntington's disease: open-label video-blinded study
15. COSTS AND RESOURCE USE ASSOCIATED WITH ALZHEIMER’S DISEASE IN ITALY: RESULTS FROM AN OBSERVATIONAL STUDY
16. Disturbo da Deficit di Attenzione e iperattività: clinica e neurobiologia
17. Étude internationale multicentrique randomisée contrôlée de l’impact de l’imagerie TEP amyloïde au florbetapir (18F) sur la prise en charge des patients
18. Excess Costs Associated With Possible Misdiagnosis of Alzheimer’s Disease Among Patients With Vascular Dementia In Italy
19. Potential effect of amyloid imaging on diagnosis and intended management of patients with cognitive decline: impact of appropriate use criterion
20. Assessment of tolerability and eeicacy of duloxetine in the treatment of depressed patients with Parkinson’s disease
21. A psychoeducational program for weight loss in patietns who have experienced weight gain during antipsychotic treatment with olanzapine
22. Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy
23. Acetylcholinesterase inhibitors in Parkinson’s disease with dementia: a clinical and brain perfusional study
24. Potential effect of amyloid imaging on diagnosis and intended management of patients with cognitive decline: Impact of appropriate use criterion
25. Prognostic value of rCBF SPECT in the predictiing response to therapy with cholinesterase inhibitors in Alzheimer's Disease
26. Contribution of cerebellum and brainstem in the control of eye movement: evidences from a functional study in a clinical model
27. Amantadine in Huntington’s disease: open-label video-blinded study
28. Predictors of cognitive-behavioural response to cholinesterase inhibitors in Alzheimer's Disease: evidence from brain perfusion SPECT
29. Effects of cholinesterase inhibitors on behavioural abnormalities in Alzheimer's Disease: evidence from a perfusional SPECT study
30. Assessment of perfusion effects of cholinesterase inhibitors in Alzheimer's Disease by 99mTc-ECD brain SPECT
31. Pharmacokinetics and pharmacodynamics of levodopa afer acute and 6 week tolcapone administration in patients with parkinson's disease
32. P.2.c.008 Assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease
33. A Psychoeducational Program for Weight Loss in Patients who have Experienced Weight Gain during Antipsychotic Treatment with Olanzapine
34. From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy
35. P.2.022 Efficacy of a psychoeducationalprogram for weight gain control in patients taking olanzapine
36. Psychiatric comorbidity in a population of Parkinson's disease patients
37. Contribution of cerebellum and brainstem in the control of eye movement: evidence from a functional study in a clinical model
38. Long-term Follow-up after Flunarizine or Nimodipine Discontinuation in Migraine Patients
39. Amitriptyline and Dexamethasone Combined Treatment in Drug-Induced Headache
40. PND27 - Excess Costs Associated With Possible Misdiagnosis of Alzheimer’s Disease Among Patients With Vascular Dementia In Italy
41. IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study.
42. Guidelines for the diagnosis of dementia and Alzheimer's disease
43. Childhood neglect and parental care perception in cocaine addicts: Relation with psychiatric symptoms and biological correlates
44. Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients
45. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
46. Correction: Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
47. Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial.
48. Treatment pattern and health care resource utilization for Taiwanese patients with migraine: a population-based study.
49. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
50. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.